BUDA, ALESSANDRO ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.063
AS - Asia 3.165
EU - Europa 2.859
SA - Sud America 469
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
Totale 13.669
Nazione #
US - Stati Uniti d'America 6.665
SG - Singapore 1.093
CN - Cina 728
IT - Italia 682
HK - Hong Kong 419
DE - Germania 407
RU - Federazione Russa 400
VN - Vietnam 399
BR - Brasile 351
SE - Svezia 339
CA - Canada 324
IE - Irlanda 235
GB - Regno Unito 178
UA - Ucraina 156
IN - India 149
FR - Francia 140
FI - Finlandia 70
BD - Bangladesh 67
TR - Turchia 50
MX - Messico 43
DK - Danimarca 41
AR - Argentina 39
ES - Italia 39
IQ - Iraq 39
JP - Giappone 39
AT - Austria 35
PL - Polonia 27
ZA - Sudafrica 27
BE - Belgio 25
NL - Olanda 24
SA - Arabia Saudita 23
PH - Filippine 21
PK - Pakistan 19
CO - Colombia 18
EC - Ecuador 18
KR - Corea 18
CZ - Repubblica Ceca 16
ID - Indonesia 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
CH - Svizzera 10
EG - Egitto 10
EU - Europa 10
MY - Malesia 10
PY - Paraguay 10
VE - Venezuela 10
AU - Australia 9
IR - Iran 9
KE - Kenya 9
PE - Perù 8
PT - Portogallo 8
RO - Romania 7
TN - Tunisia 7
A2 - ???statistics.table.value.countryCode.A2??? 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CL - Cile 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GT - Guatemala 5
JM - Giamaica 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
UY - Uruguay 5
BO - Bolivia 4
KZ - Kazakistan 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
PA - Panama 3
SC - Seychelles 3
SN - Senegal 3
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NI - Nicaragua 2
PR - Porto Rico 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 13.656
Città #
Ann Arbor 1.191
Ashburn 719
Singapore 648
Fairfield 387
Hong Kong 370
Houston 343
San Jose 332
Chandler 329
Woodbridge 322
Wilmington 268
Toronto 235
Dublin 228
Frankfurt am Main 187
Milan 171
Dearborn 169
New York 163
Seattle 157
Jacksonville 143
Cambridge 138
Ho Chi Minh City 130
Los Angeles 119
Beijing 107
Santa Clara 93
The Dalles 91
Princeton 90
Hanoi 83
Dallas 76
Chicago 75
Shanghai 69
Nanjing 68
Boardman 66
Lissone 60
Altamura 53
Buffalo 52
Munich 50
São Paulo 48
Lauterbourg 45
Lawrence 43
Fremont 42
San Diego 33
Council Bluffs 32
Orem 32
Hefei 31
Vienna 31
Rome 30
Tokyo 30
London 29
Nanchang 29
Helsinki 28
Montreal 26
Brussels 25
Guangzhou 25
Chennai 24
Lachine 24
Moscow 23
Da Nang 21
Falls Church 20
Atlanta 19
Johannesburg 19
Pune 18
Warsaw 17
Baghdad 16
Denver 16
Ottawa 16
Turku 16
Brooklyn 15
Amsterdam 14
Hangzhou 14
Jinan 13
Kunming 13
Monza 13
Nuremberg 13
Poplar 13
Seoul 13
Shenyang 13
Columbus 12
Dhaka 12
Haiphong 12
Hebei 12
Phoenix 12
Rio de Janeiro 12
Washington 12
Andover 11
Biên Hòa 11
Boston 11
Brno 11
Düsseldorf 11
Manchester 11
Paris 11
Mexico City 10
San Francisco 10
Tashkent 10
Bologna 9
Curitiba 9
Jeddah 9
Mumbai 9
Newark 9
Tianjin 9
Brasília 8
Changsha 8
Totale 8.985
Nome #
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 542
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 480
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 461
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 452
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 399
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 376
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 374
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 365
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 365
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 364
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 364
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 364
Sentinel node biopsy in endometrial cancer: an update 352
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 350
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 342
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 335
Effects of Peritoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Gynecologic Surgery 325
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 320
Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: Our experience and literature review 318
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 314
Optimizing strategies for sentinel lymph node mapping in early-stage cervical and endometrial cancer: Comparison of real-time fluorescence with indocyanine green and methylene blue 313
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 313
Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer 306
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 301
Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green Using the VITOM II ICG Exoscope for Open Surgery for Gynecologic Malignancies 297
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 293
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 287
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial 281
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 269
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 265
Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case 264
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 253
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 252
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 251
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 247
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 247
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 238
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 224
Eviscerazione pelvica 196
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 195
Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review 195
Prognostic factors in patients with vulvar cancer: the VULCAN study 179
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 175
KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer 163
Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer 149
Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study 145
Qualità di vita dopo trapianto di fegato per epatite fulminante 111
Totale 13.971
Categoria #
all - tutte 44.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022812 87 110 81 69 58 71 44 52 31 67 60 82
2022/20231.180 102 387 101 127 66 195 11 58 77 10 34 12
2023/2024803 21 22 44 45 100 219 200 27 28 3 3 91
2024/20251.727 94 181 108 82 128 81 100 74 158 305 164 252
2025/20265.063 603 231 376 562 560 269 778 211 425 397 361 290
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 13.971